Search

everythinglearnresearchcommunity

for

Search:↓

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Deslorelin effectively treats hair loss in neutered ferrets by reducing hormone levels.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Spironolactone most effective for hirsutism, but has side effects.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.